TGFB1 and renal fibrosis: Involving this mechanism, liraglutide inhibited pSmad3 and pERK1/2, downstream signalling molecules in the TGF-β1 pathway, and effectively reduced renal fibrosis, indicated by lowered fibronectin expression [144,146].